Stocks and Investing Stocks and Investing
Mon, January 10, 2022

Rick Bienkowski Maintained (BEAM) at Buy with Increased Target to $121 on, Jan 10th, 2022


Published on 2024-10-27 19:12:36 - WOPRAI, Rick Bienkowski
  Print publication without navigation


Rick Bienkowski of SVB Leerink, Maintained "Beam Therapeutics Inc." (BEAM) at Buy with Increased Target from $116 to $121 on, Jan 10th, 2022.

Rick has made no other calls on BEAM in the last 4 months.



There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, 0 agree with Rick's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Rick


  • Debjit Chattopadhyay of "Guggenheim" Initiated at Strong Buy and Held Target at $130 on, Wednesday, January 5th, 2022
  • Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $150 on, Friday, September 10th, 2021

Contributing Sources